Raphael Pharmaceutical Company Description

Raphael Pharmaceutical Inc., a pharmaceutical drug research and development company, focuses on the discovery and clinical development of life-improving drug therapies based on cannabinoids.

The company develops lead product candidate for the treatment of rheumatoid arthritis. It also intends to develop cannabinoid-based drug products for the treatment of oncology indications and other autoimmune diseases.

The company is headquartered in Tel Aviv-Jaffa, Israel.

Raphael Pharmaceutical Inc.

Country	United States
Industry	Drug Manufacturers - Specialty & Generic
Sector	Healthcare
CEO	Shlomo Pilo

Contact Details

Address: 4 Lui Paster Jaffa, Nevada 6803605 Israel
Phone	972 5 2775 5072
Website	raphaelpharmaceutical.com

Stock Details

Ticker Symbol	RAPH
Exchange	OTCMKTS
Fiscal Year	January - December
Reporting Currency	USD
ISIN Number	US27785B2088
SIC Code	2836

Key Executives

Name	Position
Shlomo Pilo	Chief Executive Officer and Director
Guy Ofir	General Counsel, Chief Financial Officer and Director
Dr. Igal Louria Hayon	Chief Technology Officer and Director